{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:43:38Z","timestamp":1789386218236,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Healthcare Insurers Innovation Foundation","award":["3080 B15-191"],"award-info":[{"award-number":["3080 B15-191"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are clinical predictors for successful medical treatment in case of early pregnancy loss (EPL)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>Use of mifepristone, BMI, number of previous uterine aspirations and the presence of minor clinical symptoms (slight vaginal bleeding or some abdominal cramps) at treatment start are predictors for successful medical treatment in case of EPL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Success rates of medical treatment for EPL vary strongly, between but also within different treatment regimens. Up until now, although some predictors have been identified, no clinical prediction model has been developed yet.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>Secondary analysis of a multicentre randomized controlled trial in 17 Dutch hospitals, executed between 28 June 2018 and 8 January 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Women with a non-viable pregnancy between 6 and 14\u2009weeks of gestational age, who opted for medical treatment after a minimum of 1 week of unsuccessful expectant management. Potential predictors for successful medical treatment of EPL were chosen based on literature and expert opinions. We internally validated the prediction model using bootstrapping techniques.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>237 out of 344 women had a successful medical EPL treatment (68.9%). The model includes the following variables: use of mifepristone, BMI, number of previous uterine aspirations and the presence of minor clinical symptoms (slight vaginal bleeding or some abdominal cramps) at treatment start. The model shows a moderate capacity to discriminate between success and failure of treatment, with an AUC of 67.6% (95% CI\u2009=\u200964.9\u201370.3%). The model had a good fit comparing predicted to observed probabilities of success but might underestimate treatment success in women with a predicted probability of success of \u223c70%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The vast majority (90.4%) of women were Caucasian, potentially leading to less optimal model performance in a non-Caucasian population. Limitations of our model are that we have not yet been able to externally validate its performance and clinical impact, and the moderate accuracy of the prediction model of 0.67.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>We developed a prediction model, aimed to improve and personalize counselling for medical treatment of EPL by providing a woman with her individual chance of complete evacuation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>The Triple M Trial, upon which this secondary analysis was performed, was funded by the Healthcare Insurers Innovation Foundation (project number 3080 B15-191).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>Clinicaltrials.gov: NCT03212352.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deac048","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T04:11:37Z","timestamp":1646712697000},"page":"936-946","source":"Crossref","is-referenced-by-count":9,"title":["Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3782-6669","authenticated-orcid":false,"given":"C C","family":"Hamel","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands"},{"name":"Department of Obstetrics and Gynaecology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Vart","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, University Medical Centre Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F P H A","family":"Vandenbussche","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Helios Klinikum Duisburg, Duisburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D D M","family":"Braat","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P L M","family":"Snijders","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S F P J","family":"Coppus","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Maxima Medical Centre, Veldhoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"2022050519294886800_deac048-B1","first-page":"168","article-title":"Clinical management guidelines for obstetrician\u2013gynecologists","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2022050519294886800_deac048-B2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/bdra.23014","article-title":"A systematic review to calculate background miscarriage rates using life table analysis","volume":"94","author":"Ammon Avalos","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2022050519294886800_deac048-B3","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","article-title":"Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases","volume":"109","author":"Ashok","year":"2002","journal-title":"BJOG"},{"key":"2022050519294886800_deac048-B4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-7824(00)00187-6","article-title":"Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost","volume":"62","author":"Bartley","year":"2000","journal-title":"Contraception"},{"key":"2022050519294886800_deac048-B5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2288-9-22","article-title":"Methodology individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine","volume":"9","author":"Broeze","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"2022050519294886800_deac048-B6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.fertnstert.2016.03.009","article-title":"Lifestyle and pregnancy loss in a contemporary cohort of women recruited before conception: the LIFE Study","volume":"106","author":"Buck Louis","year":"2016","journal-title":"Fertil Steril"},{"key":"2022050519294886800_deac048-B7","first-page":"1","article-title":"Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial","volume":"6736","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"2022050519294886800_deac048-B8","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/humrep\/dep109","article-title":"Evaluating prediction models in reproductive medicine","volume":"24","author":"Coppus","year":"2009","journal-title":"Hum Reprod"},{"key":"2022050519294886800_deac048-B9","first-page":"1","volume-title":"Making Shared Decision-Making a Reality: No Decision About Me, Without Me","author":"Coulter","year":"2011"},{"key":"2022050519294886800_deac048-B10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.AOG.0000206737.68709.3e","article-title":"Factors related to successful misoprostol treatment for early pregnancy failure","volume":"107","author":"Creinin","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2022050519294886800_deac048-B11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"2022050519294886800_deac048-B12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00404-020-05672-6","article-title":"Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding","volume":"302","author":"Fernlund","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"2022050519294886800_deac048-B13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejogrb.2005.06.010","article-title":"Women\u2019s preferences for misoprostol in case of early pregnancy failure","volume":"124","author":"Graziosi","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022050519294886800_deac048-B14","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/humrep\/deh344","article-title":"Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial","volume":"19","author":"Graziosi","year":"2004","journal-title":"Hum Reprod"},{"key":"2022050519294886800_deac048-B15","doi-asserted-by":"crossref","first-page":"100716","DOI":"10.1016\/j.eclinm.2020.100716","article-title":"Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): a double-blind placebo-controlled randomised trial","volume":"32","author":"Hamel","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2022050519294886800_deac048-B16","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression Modeling Strategies","author":"Harrell","year":"2001"},{"key":"2022050519294886800_deac048-B17","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/humrep\/dex216","article-title":"Factors influencing women\u2019s preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage","volume":"32","author":"Hentzen","year":"2017","journal-title":"Hum Reprod"},{"key":"2022050519294886800_deac048-B18","doi-asserted-by":"crossref","DOI":"10.1002\/9781118548387","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"2022050519294886800_deac048-B19","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/humrep\/deh277","article-title":"Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study","volume":"19","author":"Lashen","year":"2004","journal-title":"Hum Reprod"},{"key":"2022050519294886800_deac048-B20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/humrep\/dev274","article-title":"Dilatation and curettage increases the risk of subsequent preterm birth: a systematic review and meta-analysis","volume":"31","author":"Lemmers","year":"2016","journal-title":"Hum Reprod"},{"key":"2022050519294886800_deac048-B21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/ijo.2017.159","article-title":"Obesity during pregnancy affects sex steroid concentrations depending on fetal gender","volume":"41","author":"Maliqueo","year":"2017","journal-title":"Int J Obes"},{"key":"2022050519294886800_deac048-B22","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"2022050519294886800_deac048-B23","year":"2020"},{"key":"2022050519294886800_deac048-B24","volume-title":"Medical Treatments for Incomplete Miscarriage (Less than 24 Weeks)","author":"Neilson","year":"2009"},{"key":"2022050519294886800_deac048-B25","volume-title":"Ectopic Pregnancy and Miscarriage: Diagnosis and Initial Management","year":"2019"},{"key":"2022050519294886800_deac048-B26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"2022050519294886800_deac048-B27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2015.08.010","article-title":"Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol","volume":"93","author":"Reeves","year":"2016","journal-title":"Contraception"},{"key":"2022050519294886800_deac048-B28","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1715726","article-title":"Mifepristone pretreatment for the medical management of early pregnancy loss","volume":"378","author":"Schreiber","year":"2018","journal-title":"N Engl J Med"},{"key":"2022050519294886800_deac048-B29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.repbio.2015.02.001","article-title":"Serum biomarkers may help predict successful misoprostol management of early pregnancy failure","volume":"15","author":"Schreiber","year":"2015","journal-title":"Reprod Biol"},{"key":"2022050519294886800_deac048-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2020.04.006","article-title":"Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial","volume":"223","author":"Sonalkar","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2022050519294886800_deac048-B31","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical Prediction Models","author":"Steyerberg","year":"2009"},{"key":"2022050519294886800_deac048-B32","doi-asserted-by":"crossref","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis Research Strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLoS Med"},{"key":"2022050519294886800_deac048-B33","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ajog.2008.10.016","article-title":"Relationship of obesity to outcome of medical abortion","volume":"200","author":"Strafford","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"2022050519294886800_deac048-B34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2014.10.010","article-title":"Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study","volume":"183","author":"Van Den Berg","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022050519294886800_deac048-B35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.pec.2010.10.031","article-title":"Counseling women with early pregnancy failure: utilizing evidence, preserving preference","volume":"81","author":"Wallace","year":"2010","journal-title":"Patient Educ Couns"},{"key":"2022050519294886800_deac048-B36","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/humrep\/17.6.1638","article-title":"Expectant management versus surgical evacuation in first trimester miscarriage: health-related quality of life in randomized and non-randomized patients","volume":"17","author":"Wieringa-De Waard","year":"2002","journal-title":"Hum Reprod"},{"key":"2022050519294886800_deac048-B37","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/humrep\/dei163","article-title":"Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis","volume":"20","author":"You","year":"2005","journal-title":"Hum Reprod"},{"key":"2022050519294886800_deac048-B38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJMoa044064","article-title":"A comparison of medical management with misoprostol and surgical management for early pregnancy failure","volume":"353","author":"Zhang","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/5\/936\/43541400\/deac048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/5\/936\/43541400\/deac048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T20:21:49Z","timestamp":1651782109000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/5\/936\/6554030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3,25]]},"published-print":{"date-parts":[[2022,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac048","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2022,3,25]]}}}